Cargando…
Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments
Antibody‐mediated rejection (AMR) remains one of the most critical problems in renal transplantation, with a significant impact on patient and graft survival. In the United States, no treatment has received FDA approval jet. Studies about treatments of AMR remain controversial, limited by the absenc...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286805/ https://www.ncbi.nlm.nih.gov/pubmed/35137982 http://dx.doi.org/10.1111/ctr.14608 |